An art gallerist described her biggest challenge right now as “counteracting GLP-1s.”

If someone can turn down a cookie, they can turn down the delicious satisfaction of buying an artwork, too. I’m still in the impulse sector over here.

We tend to think of GLP-1s as weight loss drugs. But they’re already beginning to alter how people consume more broadly, from shopping and scrolling to how much we feel the urge to indulge at all. We’re becoming a society with impeccable impulse control, but at what cost?